UBS analyst AJ Rice lowered the firm’s price target on Molina Healthcare (MOH) to $145 from $170 and keeps a Neutral rating on the shares. The Medicaid and exchanges backdrop remain challenged, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target lowered to $144 from $180 at Cantor Fitzgerald
- Molina Healthcare price target lowered to $144 from $175 at TD Cowen
- Molina Healthcare Earnings Call: Growth Wins vs. Strain
- Molina Healthcare Announces Impairment Charge Amid Medicare Shift
- Molina Healthcare sees Q1 non-cash, pre-tax impairment charge of $93M